Related Experiment Video
Updated: Apr 15, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Current methods for capsular typing of Streptococcus pneumoniae
Elita Jauneikaite1, Anna S Tocheva2, Johanna M C Jefferies3
1Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton SO16 6YD, UK; Infectious Diseases, Genome Institute of Singapore, 138672, Singapore.
Insights
Tracking Streptococcus pneumoniae serotypes is crucial due to vaccine limitations. This study reviews methods for pneumococcal capsule typing to guide surveillance and future vaccine development.
Area of Science:
- Microbiology
- Vaccinology
- Genomics
Background:
- Streptococcus pneumoniae causes significant respiratory illness, particularly in young children and the elderly.
- Current pneumococcal conjugate vaccines (PCV) cover a limited number of the 98 known serotypes, necessitating surveillance for non-vaccine serotypes.
- Post-PCV implementation requires rapid, accurate, and cost-effective methods for pneumococcal serotyping.
Purpose of the Study:
- To review and describe serotyping methods for Streptococcus pneumoniae published before November 10, 2014.
- To evaluate available methods for pneumococcal capsule typing in the context of post-vaccine surveillance.
- To inform the selection of appropriate typing methods for monitoring vaccine impact and future vaccine design.
Main Methods:
- A systematic review of published pneumococcal capsule typing methods.
- Categorization of identified methods into serological, semi-automated molecular, and whole-genome sequencing approaches.
- Analysis of 16 distinct typing methods, including the gold-standard Quellung reaction.
Main Results:
- Six serological, eight semi-automated molecular, and one whole-genome sequencing method were identified.
- No single method is universally optimal for all pneumococcal typing applications.
- The Quellung reaction remains the gold-standard, but resource and sample considerations are vital for method selection.
Conclusions:
- Selecting the most appropriate pneumococcal typing method depends on laboratory resources, sample type, and desired turnaround time.
- A combination of phenotypic and genotypic methods is likely optimal for monitoring PCV impact and informing future vaccine formulations.
- Continued surveillance and development of effective typing strategies are essential for controlling pneumococcal disease.
Abstract:
Streptococcus pneumoniae is a major respiratory tract pathogen causing pneumococcal disease mainly in children aged less than five years and in the elderly. Ninety-eight different capsular types (serotypes) of pneumococci have been reported, but pneumococcal conjugate vaccines (PCV) include polysaccharide antigens against only 7, 10 or 13 serotypes. It is therefore important to track the emergence of serotypes due to the clonal expansion of non-vaccine serotypes. Increased numbers of carried and disease-causing pneumococci are now being analysed as part of the post-PCV implementation surveillance studies and hence rapid, accurate and cost-effective typing methods are important. Here we describe serotyping methods published prior to 10th November 2014 for pneumococcal capsule typing. Sixteen methods were identified; six were based on serological tests using immunological properties of the capsular epitopes, eight were semi-automated molecular tests, and one describes the identification of capsular type directly from whole genome data, which also allows for further intra and inter-genome analyses. There was no single method that could be recommended for all pneumococcal capsular typing applications. Although the Quellung reaction is still considered to be the gold-standard, laboratories should take into account the number of pneumococcal isolates and the type of samples to be used for testing, the time frame for the results and the resources available in order to select the most appropriate method. Most likely, a combination of phenotypic and genotypic methods would be optimal to monitor and evaluate the impact of pneumococcal conjugate vaccines and to provide information for future vaccine formulations.
Related Concept Videos
Special Staining Techniques
Methods of Classification and Identification
Atypical Pneumonia

